Report Detail

Medical Devices & Consumables Global Alzheimer's Disease Blood Test Kit Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4659096
  • |
  • 31 December, 2025
  • |
  • Global
  • |
  • 104 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Alzheimer's Disease Blood Test Kit market size was valued at US$ 45.8 million in 2024 and is forecast to a readjusted size of USD 146 million by 2031 with a CAGR of 18.2% during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Alzheimer's disease is a progressive neurodegenerative disorder that primarily affects the brain, leading to cognitive decline and memory loss. It is the most common cause of dementia, a syndrome characterized by a decline in cognitive function that interferes with daily life. Alzheimer's disease is named after Dr. Alois Alzheimer, who first identified the condition in 1906.
Currently, there is not significant leading product on the market, and the competition landscape for AD diagnostic reagents is relatively good. In the future, with the approval of more accurate mass spectrometry and other kits, the application of combined detection methods, and the approval of more AD treatment drugs, the AD diagnostic industry has huge development potential, and the market space may further expand.
The cerebrospinal fluid (CSF) biomarkers, that were first developed by Fujirebio more than 25 years ago, have evolved over time from research biomarkers into specialized diagnostic testing tools, and from manual usage by early adopters to a widespread implementation in fully automated routine testing today.
Diagnosis for Alzheimer’s disease using CSF samples allows the detection of four proteins: two forms of amyloid (Aβ1-42 and Aβ1-40) proteins and two forms of Tau (Total Tau and phospho-Tau) proteins. If a patient has Alzheimer’s disease, then these proteins will be present in abnormally low (Aβ1-42 and Aβ1-42/Aβ1-40 ratio) and high (Total Tau and phospho-Tau) levels. The Aβ1-42 levels and the Aβ1-42/Aβ1-40 ratio will even be low long before the symptoms of the disease start to show.
In the clinical community today, there are high hopes for the use of blood-based testing for even simpler and potentially more widespread testing for Alzheimer’s disease in clinical routine.
Rising Prevalence of Alzheimer's Disease: The increasing global prevalence of Alzheimer's disease is a significant driver for the development of early diagnosis kits. As the aging population grows, the demand for reliable diagnostic tools for early detection becomes more critical.
Focus on Early Intervention and Treatment: With the recognition that early intervention and treatment may have a more significant impact on disease progression, there is a growing emphasis on the development of tools that enable early diagnosis. This shift in therapeutic strategies encourages investment in early detection technologies.
Technological Innovations in Diagnostics: Advances in diagnostic technologies, including imaging techniques, molecular diagnostics, and blood-based assays, contribute to the development of more sophisticated and precise early diagnosis kits. These innovations enhance the sensitivity and specificity of diagnostic tools.
This report is a detailed and comprehensive analysis for global Alzheimer's Disease Blood Test Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Alzheimer's Disease Blood Test Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Alzheimer's Disease Blood Test Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Alzheimer's Disease Blood Test Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Alzheimer's Disease Blood Test Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Alzheimer's Disease Blood Test Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Alzheimer's Disease Blood Test Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fujirebio, Quanterix, People Bio, Easund Bio-tech and Pharmakea, MagQu, Solgent, Sysmex, Immuno-Biological Laboratories, Shenzhen Anqun Bioengineering, Amoneta Diagnostics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Alzheimer's Disease Blood Test Kit market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Magnetic Particle Chemiluminescence Methods
Enzyme-linked Immunoassay Methods
Chemiluminescence Immunoassay Methods
Dry Fluorescence Immunochromatography Methods
Others
Market segment by Application
Clinical Diagnosis
Research
Major players covered
Fujirebio
Quanterix
People Bio
Easund Bio-tech and Pharmakea
MagQu
Solgent
Sysmex
Immuno-Biological Laboratories
Shenzhen Anqun Bioengineering
Amoneta Diagnostics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alzheimer's Disease Blood Test Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Alzheimer's Disease Blood Test Kit, with price, sales quantity, revenue, and global market share of Alzheimer's Disease Blood Test Kit from 2020 to 2025.
Chapter 3, the Alzheimer's Disease Blood Test Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alzheimer's Disease Blood Test Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Alzheimer's Disease Blood Test Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Alzheimer's Disease Blood Test Kit.
Chapter 14 and 15, to describe Alzheimer's Disease Blood Test Kit sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Alzheimer's Disease Blood Test Kit Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Magnetic Particle Chemiluminescence Methods
    • 1.3.3 Enzyme-linked Immunoassay Methods
    • 1.3.4 Chemiluminescence Immunoassay Methods
    • 1.3.5 Dry Fluorescence Immunochromatography Methods
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Alzheimer's Disease Blood Test Kit Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Clinical Diagnosis
    • 1.4.3 Research
  • 1.5 Global Alzheimer's Disease Blood Test Kit Market Size & Forecast
    • 1.5.1 Global Alzheimer's Disease Blood Test Kit Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Alzheimer's Disease Blood Test Kit Sales Quantity (2020-2031)
    • 1.5.3 Global Alzheimer's Disease Blood Test Kit Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Fujirebio
    • 2.1.1 Fujirebio Details
    • 2.1.2 Fujirebio Major Business
    • 2.1.3 Fujirebio Alzheimer's Disease Blood Test Kit Product and Services
    • 2.1.4 Fujirebio Alzheimer's Disease Blood Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Fujirebio Recent Developments/Updates
  • 2.2 Quanterix
    • 2.2.1 Quanterix Details
    • 2.2.2 Quanterix Major Business
    • 2.2.3 Quanterix Alzheimer's Disease Blood Test Kit Product and Services
    • 2.2.4 Quanterix Alzheimer's Disease Blood Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Quanterix Recent Developments/Updates
  • 2.3 People Bio
    • 2.3.1 People Bio Details
    • 2.3.2 People Bio Major Business
    • 2.3.3 People Bio Alzheimer's Disease Blood Test Kit Product and Services
    • 2.3.4 People Bio Alzheimer's Disease Blood Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 People Bio Recent Developments/Updates
  • 2.4 Easund Bio-tech and Pharmakea
    • 2.4.1 Easund Bio-tech and Pharmakea Details
    • 2.4.2 Easund Bio-tech and Pharmakea Major Business
    • 2.4.3 Easund Bio-tech and Pharmakea Alzheimer's Disease Blood Test Kit Product and Services
    • 2.4.4 Easund Bio-tech and Pharmakea Alzheimer's Disease Blood Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Easund Bio-tech and Pharmakea Recent Developments/Updates
  • 2.5 MagQu
    • 2.5.1 MagQu Details
    • 2.5.2 MagQu Major Business
    • 2.5.3 MagQu Alzheimer's Disease Blood Test Kit Product and Services
    • 2.5.4 MagQu Alzheimer's Disease Blood Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 MagQu Recent Developments/Updates
  • 2.6 Solgent
    • 2.6.1 Solgent Details
    • 2.6.2 Solgent Major Business
    • 2.6.3 Solgent Alzheimer's Disease Blood Test Kit Product and Services
    • 2.6.4 Solgent Alzheimer's Disease Blood Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Solgent Recent Developments/Updates
  • 2.7 Sysmex
    • 2.7.1 Sysmex Details
    • 2.7.2 Sysmex Major Business
    • 2.7.3 Sysmex Alzheimer's Disease Blood Test Kit Product and Services
    • 2.7.4 Sysmex Alzheimer's Disease Blood Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Sysmex Recent Developments/Updates
  • 2.8 Immuno-Biological Laboratories
    • 2.8.1 Immuno-Biological Laboratories Details
    • 2.8.2 Immuno-Biological Laboratories Major Business
    • 2.8.3 Immuno-Biological Laboratories Alzheimer's Disease Blood Test Kit Product and Services
    • 2.8.4 Immuno-Biological Laboratories Alzheimer's Disease Blood Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Immuno-Biological Laboratories Recent Developments/Updates
  • 2.9 Shenzhen Anqun Bioengineering
    • 2.9.1 Shenzhen Anqun Bioengineering Details
    • 2.9.2 Shenzhen Anqun Bioengineering Major Business
    • 2.9.3 Shenzhen Anqun Bioengineering Alzheimer's Disease Blood Test Kit Product and Services
    • 2.9.4 Shenzhen Anqun Bioengineering Alzheimer's Disease Blood Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Shenzhen Anqun Bioengineering Recent Developments/Updates
  • 2.10 Amoneta Diagnostics
    • 2.10.1 Amoneta Diagnostics Details
    • 2.10.2 Amoneta Diagnostics Major Business
    • 2.10.3 Amoneta Diagnostics Alzheimer's Disease Blood Test Kit Product and Services
    • 2.10.4 Amoneta Diagnostics Alzheimer's Disease Blood Test Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Amoneta Diagnostics Recent Developments/Updates

3 Competitive Environment: Alzheimer's Disease Blood Test Kit by Manufacturer

  • 3.1 Global Alzheimer's Disease Blood Test Kit Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Alzheimer's Disease Blood Test Kit Revenue by Manufacturer (2020-2025)
  • 3.3 Global Alzheimer's Disease Blood Test Kit Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Alzheimer's Disease Blood Test Kit by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Alzheimer's Disease Blood Test Kit Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Alzheimer's Disease Blood Test Kit Manufacturer Market Share in 2024
  • 3.5 Alzheimer's Disease Blood Test Kit Market: Overall Company Footprint Analysis
    • 3.5.1 Alzheimer's Disease Blood Test Kit Market: Region Footprint
    • 3.5.2 Alzheimer's Disease Blood Test Kit Market: Company Product Type Footprint
    • 3.5.3 Alzheimer's Disease Blood Test Kit Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Alzheimer's Disease Blood Test Kit Market Size by Region
    • 4.1.1 Global Alzheimer's Disease Blood Test Kit Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Alzheimer's Disease Blood Test Kit Consumption Value by Region (2020-2031)
    • 4.1.3 Global Alzheimer's Disease Blood Test Kit Average Price by Region (2020-2031)
  • 4.2 North America Alzheimer's Disease Blood Test Kit Consumption Value (2020-2031)
  • 4.3 Europe Alzheimer's Disease Blood Test Kit Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Alzheimer's Disease Blood Test Kit Consumption Value (2020-2031)
  • 4.5 South America Alzheimer's Disease Blood Test Kit Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Alzheimer's Disease Blood Test Kit Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Alzheimer's Disease Blood Test Kit Sales Quantity by Type (2020-2031)
  • 5.2 Global Alzheimer's Disease Blood Test Kit Consumption Value by Type (2020-2031)
  • 5.3 Global Alzheimer's Disease Blood Test Kit Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Alzheimer's Disease Blood Test Kit Sales Quantity by Application (2020-2031)
  • 6.2 Global Alzheimer's Disease Blood Test Kit Consumption Value by Application (2020-2031)
  • 6.3 Global Alzheimer's Disease Blood Test Kit Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Alzheimer's Disease Blood Test Kit Sales Quantity by Type (2020-2031)
  • 7.2 North America Alzheimer's Disease Blood Test Kit Sales Quantity by Application (2020-2031)
  • 7.3 North America Alzheimer's Disease Blood Test Kit Market Size by Country
    • 7.3.1 North America Alzheimer's Disease Blood Test Kit Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Alzheimer's Disease Blood Test Kit Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Alzheimer's Disease Blood Test Kit Sales Quantity by Type (2020-2031)
  • 8.2 Europe Alzheimer's Disease Blood Test Kit Sales Quantity by Application (2020-2031)
  • 8.3 Europe Alzheimer's Disease Blood Test Kit Market Size by Country
    • 8.3.1 Europe Alzheimer's Disease Blood Test Kit Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Alzheimer's Disease Blood Test Kit Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Alzheimer's Disease Blood Test Kit Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Alzheimer's Disease Blood Test Kit Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Alzheimer's Disease Blood Test Kit Market Size by Region
    • 9.3.1 Asia-Pacific Alzheimer's Disease Blood Test Kit Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Alzheimer's Disease Blood Test Kit Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Alzheimer's Disease Blood Test Kit Sales Quantity by Type (2020-2031)
  • 10.2 South America Alzheimer's Disease Blood Test Kit Sales Quantity by Application (2020-2031)
  • 10.3 South America Alzheimer's Disease Blood Test Kit Market Size by Country
    • 10.3.1 South America Alzheimer's Disease Blood Test Kit Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Alzheimer's Disease Blood Test Kit Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Alzheimer's Disease Blood Test Kit Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Alzheimer's Disease Blood Test Kit Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Alzheimer's Disease Blood Test Kit Market Size by Country
    • 11.3.1 Middle East & Africa Alzheimer's Disease Blood Test Kit Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Alzheimer's Disease Blood Test Kit Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Alzheimer's Disease Blood Test Kit Market Drivers
  • 12.2 Alzheimer's Disease Blood Test Kit Market Restraints
  • 12.3 Alzheimer's Disease Blood Test Kit Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Alzheimer's Disease Blood Test Kit and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Alzheimer's Disease Blood Test Kit
  • 13.3 Alzheimer's Disease Blood Test Kit Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Alzheimer's Disease Blood Test Kit Typical Distributors
  • 14.3 Alzheimer's Disease Blood Test Kit Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Alzheimer's Disease Blood Test Kit. Industry analysis & Market Report on Alzheimer's Disease Blood Test Kit is a syndicated market report, published as Global Alzheimer's Disease Blood Test Kit Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Alzheimer's Disease Blood Test Kit market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report